Australia, July 24 -- Gerosynth Laboratories Inc., owns the trademark (2546023) for 'MABETULENE' till April 1, 2035.
Status: protected:
Registered/protected
Classes: 1 [Active chemical ingredients for use in the manufacture of anti-cancer drugs.] and 5 [Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer.]
Type of Mark: Word
Date of Acceptance: May 16
Registration Advertised: July 23
For further details contact Greg Gronholm Gronholm Patent Services.
The original document can be viewed at: https://search.ipaustr...